Our current findings revealed that CRBN expression was increased during fasting, diabetes, and HFD and in DM patients (Fig. 1), and Ad-Crbn impaired glucose clearance and insulin sensitivity when compared to those of the Ad-GFP control groups. This evidence concerns the gene INS and diabetes mellitus.